NeuPath Health Financials

NPTH Stock

CAD 0.46 0.03 6.12%

We recommend to make use of NeuPath Health analysis to find out if markets are presently mispricing the entity. We were able to interpolate and analyze data for thirty-two available fundamentals for NeuPath Health, which can be compared to its peers in the industry. The stock experiences a very speculative upward sentiment. Check odds of NeuPath Health to be traded at C$0.437 in 90 days.

NeuPath Health Balance Sheet Chart

At this time, NeuPath Health's Net Tangible Assets are fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 9.7 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 14.1 M in 2026.

Other Current Liab Total Current Liabilities Other Liab Accounts Payable

Key indicators impacting NeuPath Health's financial strength include:

Operating Margin

0.0459

Profit Margin

(0.01)

Return On Equity

(0.02)

Please note, the imprecision that can be found in NeuPath Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NeuPath Health. Check NeuPath Health's Beneish M Score to see the likelihood of NeuPath Health's management manipulating its earnings.

NeuPath Health Stock Summary

NeuPath Health competes with DIRTT Environmental, Wilmington Capital, Queens Road, HPQ Silicon, and Waste Management. NeuPath Health Inc. provides chronic pain management services in Canada. The company operates 13 clinics under the Centres for Pain Management and InMedic Creative Medicine brands in Ontario and Alberta. NEUPATH HEALTH operates under Medical Care Facilities classification in Exotistan and is traded on Commodity Exchange.

Foreign Associate	USA
Specialization	Health Care, Health Care Equipment & Services
Instrument	Canada Stock View All
Exchange	TSX Venture Exchange
ISIN	CA64133P1009
Business Address	110 Matheson Blvd
Sector	Health Care Providers & Services
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.neupath.com
Phone	905 858 1368
Currency	CAD - Canadian Dollar

You should never invest in NeuPath Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NeuPath Stock, because this is throwing your money away. Analyzing the key information contained in NeuPath Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

NeuPath Health Key Financial Ratios

There are many critical financial ratios that NeuPath Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NeuPath Health reports annually and quarterly.

	Revenue	72.81 M
	Gross Profit	15.16 M
	EBITDA	3.03 M
	Net Income	(728 K)
	Total Asset	41.3 M

More Fundamentals

NeuPath Health Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Other Liab	96K	59K	215K	33K	29.7K	28.2K
Net Tangible Assets	(10.9M)	7.8M	2.1M	63K	72.5K	76.1K
Retained Earnings	(21.8M)	(25.9M)	(26.0M)	(26.8M)	(24.1M)	(25.3M)
Accounts Payable	7.5M	8.8M	7.5M	8.4M	9.7M	6.8M
Net Receivables	6.6M	7.0M	6.7M	7.4M	8.5M	6.7M
Other Current Assets	988K	670K	606K	529K	608.4K	591.3K
Total Current Assets	15.4M	11.1M	10.7M	11.1M	12.8M	12.3M
Common Stock	11.5M	32.8M	36.8M	39.9M	45.9M	24.6M
Total Assets	51.3M	45.1M	41.8M	41.3M	37.2M	35.1M
Cash	5.9M	1.5M	3.2M	2.9M	2.6M	3.4M
Long Term Debt	4.9M	5.0M	3.7M	5.4M	4.9M	3.9M
Total Liab	25.5M	23.4M	19.9M	19.9M	17.9M	18.1M
Net Invested Capital	34.2M	28.6M	27.7M	27.2M	24.4M	23.6M
Short Long Term Debt	3.4M	3.1M	195K	5.8M	5.2M	3.2M
Capital Stock	36.8M	39.9M	44.1M	44.0M	50.7M	38.4M
Net Working Capital	1.7M	(2.8M)	1.5M	(4.3M)	(3.8M)	(3.6M)
Intangible Assets	3.1M	1.0M	707K	629K	566.1K	1.1M

NeuPath Health Key Income Statement Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	876K	832K	928K	945K	1.1M	960.6K
Ebit	(661K)	(820K)	(1.8M)	(1.3M)	(1.4M)	(1.5M)
Income Tax Expense	(85K)	198K	(17K)	194K	223.1K	234.3K
Tax Provision	(17K)	194K	246K	212K	243.8K	137.1K
Net Interest Income	(842K)	(810K)	(919K)	(945K)	(1.1M)	(1.1M)
Total Revenue	60.9M	62.7M	66.1M	72.8M	83.7M	65.9M
Gross Profit	11.1M	10.8M	12.3M	13.9M	15.9M	12.4M
Operating Income	(1.8M)	(1.3M)	442K	1.4M	1.6M	1.7M
Cost Of Revenue	49.8M	51.8M	53.8M	58.9M	67.8M	53.5M
Income Before Tax	(3.2M)	(4.1M)	55K	(273K)	(314.0K)	(329.6K)
Net Income	(3.2M)	(4.2M)	(107K)	(728K)	(837.2K)	(879.1K)

NeuPath Health Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Change In Cash	(4.9M)	(4.4M)	1.7M	(254K)	(228.6K)	(217.2K)
Net Borrowings	(3.6M)	(3.7M)	(3.2M)	(1.9M)	(1.7M)	(1.6M)
Depreciation	3.1M	2.7M	2.6M	2.3M	2.6M	2.4M
Capital Expenditures	411K	1.2M	353K	948K	1.1M	1.1M
Net Income	(3.2M)	(4.2M)	(107K)	(728K)	(837.2K)	(879.1K)
Change To Netincome	3.3M	3.1M	889K	2.0M	2.3M	2.3M
End Period Cash Flow	5.9M	1.5M	3.2M	2.9M	2.6M	3.0M
Investments	(3.5M)	(1.7M)	1.6M	(1.1M)	(996.3K)	(946.5K)
Free Cash Flow	1.2M	(934K)	2.7M	1.7M	1.9M	2.0M
Other Non Cash Items	644K	103K	679K	773K	695.7K	863.5K

NeuPath Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NeuPath Health's current stock value. Our valuation model uses many indicators to compare NeuPath Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NeuPath Health competition to find correlations between indicators driving NeuPath Health's intrinsic value. More Info.

NeuPath Health is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeuPath Health's earnings, one of the primary drivers of an investment's value.

NeuPath Health Other Current Liab Over Time

Most indicators from NeuPath Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuPath Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuPath Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Tax Provision is likely to drop to about 137.1 K in 2026. Selling General Administrative is likely to drop to about 10.1 M in 2026

	2023	2024	2025	2026 (projected)
Gross Profit	12.3M	13.9M	15.9M	12.4M
Total Revenue	66.1M	72.8M	83.7M	65.9M

Gross Profit Total Revenue

NeuPath Health fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Other Current Assets	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Total Liab
Other Current Liab		-0.59	0.81	-0.89	0.97	-0.93	-0.85	-0.83	-0.41	-0.81	-0.96	-0.9	-0.5	-0.96	-0.53	0.98	-0.62	-0.64	-0.69	-0.76	0.63	-0.8	-0.95	0.54	-0.52	0.92
Total Current Liabilities	-0.59		-0.48	0.3	-0.73	0.79	0.9	0.68	0.71	0.48	0.65	0.77	0.19	0.52	0.4	-0.53	0.22	0.52	0.47	0.55	-0.4	0.61	0.59	-0.5	0.37	-0.51
Other Liab	0.81	-0.48		-0.74	0.84	-0.79	-0.77	-0.79	-0.29	-0.7	-0.81	-0.81	-0.33	-0.79	-0.35	0.81	-0.5	-0.45	-0.55	-0.63	0.54	-0.66	-0.8	0.52	-0.34	0.81
Net Tangible Assets	-0.89	0.3	-0.74		-0.78	0.72	0.62	0.76	0.37	0.93	0.84	0.69	0.65	0.96	0.31	-0.93	0.86	0.41	0.4	0.46	-0.54	0.56	0.78	-0.41	0.31	-0.85
Retained Earnings	0.97	-0.73	0.84	-0.78		-0.97	-0.94	-0.88	-0.49	-0.75	-0.95	-0.96	-0.47	-0.9	-0.55	0.93	-0.52	-0.64	-0.72	-0.78	0.6	-0.77	-0.93	0.52	-0.54	0.87
Accounts Payable	-0.93	0.79	-0.79	0.72	-0.97		0.96	0.86	0.44	0.71	0.97	0.98	0.45	0.86	0.59	-0.9	0.43	0.7	0.76	0.85	-0.57	0.83	0.94	-0.57	0.57	-0.82
Net Receivables	-0.85	0.9	-0.77	0.62	-0.94	0.96		0.87	0.63	0.7	0.89	0.95	0.37	0.79	0.46	-0.82	0.44	0.6	0.62	0.73	-0.49	0.75	0.84	-0.55	0.46	-0.77
Other Current Assets	-0.83	0.68	-0.79	0.76	-0.88	0.86	0.87		0.6	0.84	0.86	0.9	0.69	0.87	0.6	-0.86	0.64	0.66	0.61	0.58	-0.54	0.62	0.75	-0.24	0.62	-0.67
Other Stockholder Equity	-0.41	0.71	-0.29	0.37	-0.49	0.44	0.63	0.6		0.65	0.39	0.43	0.34	0.48	0.06	-0.41	0.61	0.12	-0.01	-0.05	-0.3	0.17	0.24	-0.1	0.08	-0.4
Total Current Assets	-0.81	0.48	-0.7	0.93	-0.75	0.71	0.7	0.84	0.65		0.79	0.69	0.68	0.93	0.26	-0.87	0.93	0.37	0.27	0.32	-0.49	0.5	0.68	-0.35	0.27	-0.78
Common Stock	-0.96	0.65	-0.81	0.84	-0.95	0.97	0.89	0.86	0.39	0.79		0.96	0.57	0.93	0.51	-0.96	0.58	0.62	0.69	0.81	-0.51	0.78	0.95	-0.53	0.5	-0.86
Property Plant Equipment	-0.9	0.77	-0.81	0.69	-0.96	0.98	0.95	0.9	0.43	0.69	0.96		0.5	0.84	0.59	-0.88	0.42	0.69	0.75	0.85	-0.49	0.79	0.91	-0.49	0.59	-0.76
Total Assets	-0.5	0.19	-0.33	0.65	-0.47	0.45	0.37	0.69	0.34	0.68	0.57	0.5		0.61	0.42	-0.58	0.67	0.31	0.31	0.21	-0.25	0.07	0.34	0.2	0.43	-0.24
Total Stockholder Equity	-0.96	0.52	-0.79	0.96	-0.9	0.86	0.79	0.87	0.48	0.93	0.93	0.84	0.61		0.46	-0.98	0.78	0.58	0.55	0.61	-0.6	0.72	0.88	-0.47	0.47	-0.9
Property Plant And Equipment Net	-0.53	0.4	-0.35	0.31	-0.55	0.59	0.46	0.6	0.06	0.26	0.51	0.59	0.42	0.46		-0.45	-0.02	0.93	0.9	0.64	-0.68	0.59	0.51	0.04	0.99	-0.22
Net Debt	0.98	-0.53	0.81	-0.93	0.93	-0.9	-0.82	-0.86	-0.41	-0.87	-0.96	-0.88	-0.58	-0.98	-0.45		-0.71	-0.58	-0.6	-0.7	0.52	-0.75	-0.93	0.51	-0.47	0.91
Cash	-0.62	0.22	-0.5	0.86	-0.52	0.43	0.44	0.64	0.61	0.93	0.58	0.42	0.67	0.78	-0.02	-0.71		0.07	-0.04	0.02	-0.27	0.21	0.44	-0.18	0.01	-0.64
Non Current Assets Total	-0.64	0.52	-0.45	0.41	-0.64	0.7	0.6	0.66	0.12	0.37	0.62	0.69	0.31	0.58	0.93	-0.58	0.07		0.88	0.75	-0.64	0.81	0.67	-0.23	0.94	-0.42
Non Currrent Assets Other	-0.69	0.47	-0.55	0.4	-0.72	0.76	0.62	0.61	-0.01	0.27	0.69	0.75	0.31	0.55	0.9	-0.6	-0.04	0.88		0.88	-0.65	0.74	0.73	-0.22	0.88	-0.46
Other Assets	-0.76	0.55	-0.63	0.46	-0.78	0.85	0.73	0.58	-0.05	0.32	0.81	0.85	0.21	0.61	0.64	-0.7	0.02	0.75	0.88		-0.4	0.86	0.89	-0.55	0.63	-0.63
Long Term Debt	0.63	-0.4	0.54	-0.54	0.6	-0.57	-0.49	-0.54	-0.3	-0.49	-0.51	-0.49	-0.25	-0.6	-0.68	0.52	-0.27	-0.64	-0.65	-0.4		-0.55	-0.51	0.24	-0.6	0.52
Good Will	-0.8	0.61	-0.66	0.56	-0.77	0.83	0.75	0.62	0.17	0.5	0.78	0.79	0.07	0.72	0.59	-0.75	0.21	0.81	0.74	0.86	-0.55		0.9	-0.68	0.59	-0.78
Common Stock Shares Outstanding	-0.95	0.59	-0.8	0.78	-0.93	0.94	0.84	0.75	0.24	0.68	0.95	0.91	0.34	0.88	0.51	-0.93	0.44	0.67	0.73	0.89	-0.51	0.9		-0.66	0.51	-0.91
Non Current Liabilities Total	0.54	-0.5	0.52	-0.41	0.52	-0.57	-0.55	-0.24	-0.1	-0.35	-0.53	-0.49	0.2	-0.47	0.04	0.51	-0.18	-0.23	-0.22	-0.55	0.24	-0.68	-0.66		0.09	0.7
Capital Lease Obligations	-0.52	0.37	-0.34	0.31	-0.54	0.57	0.46	0.62	0.08	0.27	0.5	0.59	0.43	0.47	0.99	-0.47	0.01	0.94	0.88	0.63	-0.6	0.59	0.51	0.09		-0.23
Total Liab	0.92	-0.51	0.81	-0.85	0.87	-0.82	-0.77	-0.67	-0.4	-0.78	-0.86	-0.76	-0.24	-0.9	-0.22	0.91	-0.64	-0.42	-0.46	-0.63	0.52	-0.78	-0.91	0.7	-0.23

Click cells to compare fundamentals

NeuPath Health Account Relationship Matchups

NeuPath Health fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Other Liab	96K	59K	215K	33K	29.7K	28.2K
Net Tangible Assets	(10.9M)	7.8M	2.1M	63K	72.5K	76.1K
Retained Earnings	(21.8M)	(25.9M)	(26.0M)	(26.8M)	(24.1M)	(25.3M)
Accounts Payable	7.5M	8.8M	7.5M	8.4M	9.7M	6.8M
Net Receivables	6.6M	7.0M	6.7M	7.4M	8.5M	6.7M
Other Current Assets	988K	670K	606K	529K	608.4K	591.3K
Total Current Assets	15.4M	11.1M	10.7M	11.1M	12.8M	12.3M
Common Stock	11.5M	32.8M	36.8M	39.9M	45.9M	24.6M
Total Assets	51.3M	45.1M	41.8M	41.3M	37.2M	35.1M
Cash	5.9M	1.5M	3.2M	2.9M	2.6M	3.4M
Long Term Debt	4.9M	5.0M	3.7M	5.4M	4.9M	3.9M
Total Liab	25.5M	23.4M	19.9M	19.9M	17.9M	18.1M
Net Invested Capital	34.2M	28.6M	27.7M	27.2M	24.4M	23.6M
Short Long Term Debt	3.4M	3.1M	195K	5.8M	5.2M	3.2M
Capital Stock	36.8M	39.9M	44.1M	44.0M	50.7M	38.4M
Net Working Capital	1.7M	(2.8M)	1.5M	(4.3M)	(3.8M)	(3.6M)
Intangible Assets	3.1M	1.0M	707K	629K	566.1K	1.1M

NeuPath Health Thematic Clasifications

NeuPath Health is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers

Health Management

View

This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

NeuPath Health February 10, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of NeuPath Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NeuPath Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeuPath Health based on widely used predictive technical indicators. In general, we focus on analyzing NeuPath Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeuPath Health's daily price indicators and compare them against related drivers.

	Downside Deviation	4.61
	Information Ratio	0.0983
	Maximum Drawdown	22.82
	Value At Risk	(6.12)
	Potential Upside	7.5

Additional Tools for NeuPath Stock Analysis

When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC